Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Harrow Health (HROW) stock
Learn how to easily invest in Harrow Health stock.
Harrow Health, Inc is a drug manufacturers-specialty & generic business based in the US. Harrow Health shares (HROW) are listed on the NASDAQ and all prices are listed in US Dollars. Harrow Health employs 125 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Harrow Health
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – HROW – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- HROW shares summary
- Compare share dealing platforms
- Is HROW stock a buy or sell?
- Stock performance over time
- Can I short HROW shares?
- Are HROW shares over-valued?
- Harrow Health's financials
- How volatile are HROW shares?
- Does Harrow Health pay a dividend?
- Have HROW shares ever split?
- Other common questions
Harrow Health stock price (NASDAQ: HROW)Use our graph to track the performance of HROW stocks over time.
Harrow Health shares at a glance
|Latest market close||$9.20|
|52-week range||$4.65 - $11.24|
|50-day moving average||$8.65|
|200-day moving average||$8.32|
|Wall St. target price||$14.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.37|
Buy Harrow Health shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Harrow Health stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Harrow Health price performance over time
|1 week (2021-07-15)||N/A|
|1 month (2021-06-25)||-11.28%|
|3 months (2021-04-26)||14.00%|
|6 months (2021-01-22)||N/A|
|1 year (2020-07-22)||N/A|
|2 years (2019-07-22)||N/A|
|3 years (2018-07-22)||N/A|
|5 years (2016-07-22)||N/A|
Is Harrow Health under- or over-valued?
Valuing Harrow Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Harrow Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Harrow Health's P/E ratio
Harrow Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 21x. In other words, Harrow Health shares trade at around 21x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Harrow Health's EBITDA
Harrow Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $6.4 million.
The EBITDA is a measure of a Harrow Health's overall financial performance and is widely used to measure a its profitability.
Harrow Health financials
|Revenue TTM||$52.5 million|
|Operating margin TTM||8.18%|
|Gross profit TTM||$34.4 million|
|Return on assets TTM||5.2%|
|Return on equity TTM||45.32%|
|Market capitalisation||$207.3 million|
TTM: trailing 12 months
Shorting Harrow Health shares
There are currently 1.2 million Harrow Health shares held short by investors – that's known as Harrow Health's "short interest". This figure is 36.7% down from 1.9 million last month.
There are a few different ways that this level of interest in shorting Harrow Health shares can be evaluated.
Harrow Health's "short interest ratio" (SIR)
Harrow Health's "short interest ratio" (SIR) is the quantity of Harrow Health shares currently shorted divided by the average quantity of Harrow Health shares traded daily (recently around 419662.80701754). Harrow Health's SIR currently stands at 2.85. In other words for every 100,000 Harrow Health shares traded daily on the market, roughly 2850 shares are currently held short.
However Harrow Health's short interest can also be evaluated against the total number of Harrow Health shares, or, against the total number of tradable Harrow Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Harrow Health's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Harrow Health shares in existence, roughly 50 shares are currently held short) or 0.0624% of the tradable shares (for every 100,000 tradable Harrow Health shares, roughly 62 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Harrow Health.
Find out more about how you can short Harrow Health stock.
Harrow Health share dividends
We're not expecting Harrow Health to pay a dividend over the next 12 months.
Have Harrow Health's shares ever split?
Harrow Health's shares were split on a 1:5 basis on 7 February 2013. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Harrow Health shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Harrow Health shares which in turn could have impacted Harrow Health's share price.
Harrow Health share price volatility
Over the last 12 months, Harrow Health's shares have ranged in value from as little as $4.65 up to $11.24. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Harrow Health's is 0.8993. This would suggest that Harrow Health's shares are less volatile than average (for this exchange).
Harrow Health overview
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and Visionology, a membership-based online eye health and medication platform. The company also holds equity interests in Surface Ophthalmics, Inc. , a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc. , a commercial-stage pharmaceutical company that engages in developing and commercializing drug products.
Stocks similar to Harrow Health
Harrow Health in the news
NovaBay Pharmaceuticals Partners with Harrow Health’s ImprimisRx® to Promote Prescription Avenova
NovaBay Pharmaceuticals Partners with Harrow Health’s ImprimisRx® to Promote Prescription Avenova
NovaBay partners with Harrow Health subsidiary to promote Avenova
Frequently asked questionsWhat percentage of Harrow Health is owned by insiders or institutions?
Currently 11.196% of Harrow Health shares are held by insiders and 56.137% by institutions. How many people work for Harrow Health?
Latest data suggests 125 work at Harrow Health. When does the fiscal year end for Harrow Health?
Harrow Health's fiscal year ends in December. Where is Harrow Health based?
Harrow Health's address is: 102 Woodmont Boulevard, Nashville, TN, United States, 37205 What is Harrow Health's ISIN number?
Harrow Health's international securities identification number is: US4158581094 What is Harrow Health's CUSIP number?
Harrow Health's Committee on Uniform Securities Identification Procedures number is: 415858109
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert